Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Ablynx management update

    Ablynx N.V. (Euronext:ABLX), Ghent, Belgium Business: Antibodies Hired: Johan Heylen as chief commercial officer, formerly an executive director and global commercial cancer immunotherapeutics lead at GlaxoSmithKline …

    Published on 11/24/2014
  • Alexion management update

    Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Business: Hematology, Neurology, Endocrine/Metabolic Promoted: Julie ONeill to EVP of global operations, effective Jan. 1, 2015, from SVP of global …

    Published on 11/24/2014
  • Antares management update

    Antares Pharma Inc. (NASDAQ:ATRS), Ewing, N.J. Business: Drug delivery Hired: James Fickenscher as SVP and CFO, formerly CFO of Auxilium Pharmaceuticals Inc.

    Published on 11/24/2014
  • Ares Life Sciences management update

    Ares Life Sciences, Geneva, Switzerland Business: Finance Transitioned: Rick Russell, CEO of Ares Allergy Holdings Inc. company, to president and CEO of Greer Laboratories Inc., which Ares Life Sciences acquired; he …

    Published on 11/24/2014
  • BioNano Genomics, Inc. board of directors update

    BioNano Genomics, Inc., San Diego, Calif. Business: Diagnostic, Genomics, Supply/Service Appointed: Darren Chai, executive director at Legend Capital; and Campbell Murray, managing director at Novartis Venture Fund

    Published on 11/24/2014
  • bluebird bio management update

    bluebird bio Inc. (NASDAQ:BLUE), Cambridge, Mass. Business: Gene/Cell therapy, Hematology, Neurology Hired: James DeTore as CFO, principal financial officer and treasurer, formerly VP of corporate finance at Ironwood …

    Published on 11/24/2014
  • Bone Biologics management update

    Bone Biologics Corp., Edison, N.J. Business: Musculoskeletal Hired: Deina Walsh as CFO

    Published on 11/24/2014
  • BSD Medical management update

    BSD Medical Corp. (NASDAQ:BSDM), Salt Lake City, Utah Business: Cancer Hired: Clint Carnell as president, CEO, and a director, formerly an executive in residence at Covidien plc; he succeeds Harold Wolcott

    Published on 11/24/2014
  • Glionova board of directors update

    Glionova Therapeutics, Stockholm, Sweden Business: Cancer Appointed: Johan Christenson, partner at HealthCap; and Nanna Lueneborg, investment director at Novo Seeds at Novo A/S

    Published on 11/24/2014
  • Lion Biotechnologies management update

    Lion Biotechnologies Inc. (OTCQB:LBIO), Woodland Hills, Calif. Business: Cancer Departing: Manish Singh as CEO, effective Dec. 31, and as a director, effective immediately

    Published on 11/24/2014
  • NewLink management update

    NewLink Genetics Corp. (NASDAQ:NLNK), Ames, Iowa Business: Cancer Hired: Thomas Monath CSO and COO of NewLinks BioProtection Systems Corp. subsidiary

    Published on 11/24/2014
  • Pivotal Therapeutics management update

    Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Departed: Prakash Gowd as CFO; he is succeeded by CEO Eugene Bortoluzzi

    Published on 11/24/2014
  • Retrophin management update

    Retrophin Inc. (NASDAQ:RTRX), New York, N.ZZZ. Business: Renal, Musculoskeletal, Pulmonary Hired: Laura Clague as SVP and CFO, formerly CFO of San Diego and Ohio operations at Amylin Pharmaceuticals Inc., which Bristol-…

    Published on 11/24/2014
  • Seattle Genetics management update

    Seattle Genetics Inc. (NASDAQ:SGEN), Bothell, Wash. Business: Cancer, Autoimmune Hired: Jean Liu as general counsel, EVP of legal affairs, and corporate secretary, formerly VP and general counsel at Halozyme …

    Published on 11/24/2014
  • Seres Health management update

    Seres Health Inc., Cambridge, Mass. Business: Endocrine/Metabolic, Inflammation, Infectious Hired: Eric Shaff as CFO, formerly VP of corporate finance at Momenta Pharmaceuticals Inc.

    Published on 11/24/2014
  • Vectura management update

    Vectura Group plc (LSE:VEC), Chippenham, U.K. Business: Pulmonary, Inflammation, Drug delivery Hired: Andrew Oakley as CFO, company secretary and a director, effective Jan. 1, 2015, formerly CFO of Actelion Ltd.; he …

    Published on 11/24/2014
  • Zealand Pharma management update

    Zealand Pharma A/S (CSE:ZEAL), Glostrup, Denmark Business: Endocrine/Metabolic, Cardiovascular, Gastrointestinal Hired: Britt Meelby Jensen as CEO, effective Jan. 15, 2015, formerly CEO of Dako A/S, which Agilent …

    Published on 11/24/2014
  • AcelRx management update

    AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX), Redwood City, Calif. Business: Neurology, Drug delivery Departing: Richard King as president and CEO

    Published on 11/17/2014
  • Actavis management update

    Actavis plc (NYSE:ACT), Dublin, Ireland Business: Generics, Genitourinary Hired: Maria Teresa Hilado as CFO, effective Dec. 8, formerly SVP of finance and treasurer at PepsiCo Inc.; she succeeds R. Todd Joyce

    Published on 11/17/2014
  • Alchemia management update

    Alchemia Ltd. (ASX:ACL), Brisbane, Australia Business: Chemistry, Cancer, Hematology Departed: Thomas Liquard as CEO

    Published on 11/17/2014
  • Atterocor management update

    Atterocor Inc., Ann Arbor, Mich. Business: Cancer Hired: Pharis Mohideen as CMO, formerly VP of clinical development at Shionogi & Co. Ltd.'s Shionogi Inc. U.S. company

    Published on 11/17/2014
  • Celtaxsys Inc. management update

    Celtaxsys Inc., Atlanta, Ga. Business: Pulmonary Hired: Sanjeev Ahuja as CMO, formerly CMO of On Target Laboratories LLC

    Published on 11/17/2014
  • Cubist management update

    Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Business: Infectious Promoted: Patrick Vink to EVP and COO from SVP and general manager of Cubist's international business, effective Jan. 1, 2015; he succeeds…

    Published on 11/17/2014
  • Horizon Pharma management update

    Horizon Pharma plc (NASDAQ:HZNP), Dublin, Ireland Business: Autoimmune, Inflammation, Neurology Hired: John Kody as EVP and chief commercial officer, effective Nov. 24, formerly president at Danaher's Corp.'s Leica …

    Published on 11/17/2014
  • Insulet management update

    Insulet Corp. (NASDAQ:PODD), Bedford, Mass. Business: Drug delivery, Endocrine/Metabolic Hired: Brad Thomas as EVP of human resources and organizational development, a newly created position, formerly CEO of The HR …

    Published on 11/17/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993